Yoko Oshima

NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers

Yoko Oshima, Hideaki Shimada, Satoshi Yajima et al. · Journal of Gastroenterology · 2015 · 77 citations · Full text

Medicine, Oncology, Cancer Immunology +15

Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer

Takashi Suzuki, Hideaki Shimada, Tatsuki Nanami et al. · Surgery Today · 2016 · 57 citations · Full text

Veterinary Medicine, Immunology, Oncology +16

Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer

Jin Moriyama, Yoko Oshima, Tatsuki Nanami et al. · Surgery Today · 2021 · 42 citations · Full text

Medicine, Oncology, Surgery +12

Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinoma

Takashi Suzuki, Satoshi Yajima, Nobuki Ishioka et al. · Esophagus · 2018 · 30 citations

Medicine, Oncology, Pathology +15

High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer

Masaaki Ito, Satoshi Yajima, Takashi Suzuki et al. · Cancer Medicine · 2019 · 29 citations · Full text

Medicine, Oncology, Surgery +17